Vimarsana
Biggest News Aggregation in the World

Dilisym Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dilisym Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dilisym Services Today - Breaking & Trending Today

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment - Vimarsana News

Researchers Use the Simulations Plus DILIsym® Platform to Predict Safety of Combined CBD and VPA Treatment

Elevated ALT levels during clinical trials led researchers to use quantitative systems toxicology software to better understand potential underlying mechanisms ... -Today at 08:34 am- MarketScreener

Researchers Use the Simulations Plus DILIsym Platform to Predict Safety of Combined CBD and VPA Treatment - Vimarsana News

Researchers Use the Simulations Plus DILIsym Platform to Predict Safety of Combined CBD and VPA Treatment

15.08.2023 - Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today shared an article published in the July 2023 issue of Clinical Pharmacology & Therapeutics in ... Seite 1

Simulations Plus Buys Immunetrics - San Fernando Valley Business Journal - Vimarsana News

Simulations Plus Buys Immunetrics - San Fernando Valley Business Journal

Firms focus on drug-modeling software.

Source: sfvbj.com
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes - Vimarsana News

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes

Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software... | May 10, 2023

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug - Vimarsana News

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated pulmonary software and services package. This targeted package will support pharmaceuti...